FOXM1 predicts disease progression in non-muscle invasive bladder cancer

被引：0
|
作者：
Sebastien Rinaldetti
Ralph Wirtz
Thomas Stefan Worst
Arndt Hartmann
Johannes Breyer
Lars Dyrskjot
Philipp Erben
机构：
[1] University of Heidelberg,Department of Hematology and Oncology, University Medical Centre Mannheim, Medical Faculty Mannheim
[2] Stratifyer Molecular Pathology,Department of Urology, University Medical Centre Mannheim, Medical Faculty Mannheim
[3] University of Heidelberg,Institute of Pathology
[4] University Hospital Erlangen,Department of Urology
[5] University of Regensburg,Department of Molecular Medicine
[6] Aarhus University Hospital,Department of Clinical Medicine
[7] Aarhus University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Molecular subtypes; FOXM1; Progression-free survival; Biomarker; Bladder cancer; MKI67;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1701 / 1709
页数：8
相关论文
共 50 条
  • [41] Update on the management of non-muscle invasive bladder cancer
    Aldousari, Saad
    Kassouf, Wassim
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2010, 4 (01): : 56 - 64
  • [42] TULA in recurrent non-muscle invasive bladder cancer
    Sarkar, Somita
    Mayor, Nikhil
    Mostafid, Hugh
    TRENDS IN UROLOGY & MENS HEALTH, 2020, 11 (01) : 18 - 19
  • [43] NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG
    Turker, Polat
    Turkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (09): : 833 - 840
  • [44] Immune Therapies in Non-Muscle Invasive Bladder Cancer
    Ho, Philip L.
    Williams, Stephen B.
    Kamat, Ashish M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (02)
  • [45] ABLASTIC TUR IN NON-MUSCLE INVASIVE BLADDER CANCER
    Voldohin, Alexander
    Levchenko, Vyacheslav
    Aiman, Abu Trabi
    Idalov, Aub
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A89 - A89
  • [46] The present and future of non-muscle invasive bladder cancer
    Moschini, Marco
    Roghmann, Florian
    Xylinas, Evanguelos
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 1 - 1
  • [47] Valrubicin in refractory non-muscle invasive bladder cancer
    Sharma, Pranav
    Zargar-Shoshtari, Kamran
    Sexton, Wade J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (12) : 1379 - 1387
  • [48] Active surveillance for non-muscle invasive bladder cancer
    Marcq, Gautier
    Henon, Francois
    Ouzaid, Idir
    Fantoni, Jean Christophe
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 54 - 60
  • [49] Intravesical gemcitabine for non-muscle invasive bladder cancer
    Han, Mi Ah
    Maisch, Philipp
    Jung, Jae Hung
    Hwang, Jun Eul
    Narayan, Vikram
    Cleves, Anne
    Hwang, Eu Chang
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (06):
  • [50] Diagnostic biomarkers in non-muscle invasive bladder cancer
    Izak Faiena
    Charles J. Rosser
    Karim Chamie
    Hideki Furuya
    World Journal of Urology, 2019, 37 : 2009 - 2016
12345